Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years old, of any gender
- People who have been diagnosed with both lupus and fibromyalgia or chronic widespread pain by a licensed rheumatologist
- People whose medications have remained the same and stable without changes
Who may not be able to join:
- People with serious psychiatric conditions (such as schizophrenia or bipolar disorder) that are not controlled by medication
- People who are currently experiencing thoughts of suicide
- People with an alcohol or substance use disorder that is not being treated
- People with significant difficulties with memory, thinking, or understanding
- People whose medications have changed in the past 3 months
- People who are currently taking part in another treatment study
- People who are currently involved in a legal case or disability application related to their health
- People who are unable to use a computer and/or smartphone
- People with little or no access to the internet
- People who are unable to communicate in English
- People who do not complete the required assessments at the start of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dan Kaufmann, PhD, University of Utah
Phone: 385-351-9058
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Widespread pain index at baseline; Widespread pain index a week after treatment compared to baseline; Symptom Severity Score at baseline; Change in the severity scale after treatment compared to baseline.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.